Cargando…
Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
We report the cases of two adolescent siblings with severe atopic dermatitis, who, despite weighing approximately 40kg, presented a good response to dupilumab with the off-label dose for individuals aged 12 years and weighing 60kg. Both had already used cyclosporine, azathioprine, methotrexate and o...
Autores principales: | Giavina-Bianchi, Mara, Giavina-Bianchi, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081439/ https://www.ncbi.nlm.nih.gov/pubmed/33978100 http://dx.doi.org/10.31744/einstein_journal/2021RC6064 |
Ejemplares similares
-
Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2019) -
Accuracy and efficiency of telemedicine in atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2020) -
Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
por: MARESCHAL, Adrien, et al.
Publicado: (2020) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
por: Xu, Xinghua, et al.
Publicado: (2017)